Atlas Trials

Phase I Study of the Combination of MLN9708 and Fulvestrant

Clinical trial NCT02384746 · TERMINATED

Trial details

NCT number
NCT02384746
Sponsor
Dartmouth-Hitchcock Medical Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2015-06-02
Primary completion
2018-04-12
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.